No evidence of progressive disease defined as a 25 increase from nadir in the sum of the product of the diameters SPD of any lymph node previously identified as abnormal prior to autologous transplant or the appearance of any new lymph node greater than 1.5 cm in greatest diameter new bone marrow involvement or new solid organ nodule greater than 1 cm in diameter This restaging study will be performed at least 28 days after the autologous transplant and within 60 days prior to admission for allogeneic transplant Status of stable disease SD is acceptable to proceed to allogeneic transplant 